SB
Sino Biopharmaceutical Limited
SBMFF · OTC
$0.70 -0.84% (-$0.01)
1M -5.86%
Market Cap ¥82.9B
P/E Ratio 36.32x
Div. Yield 2.57%
ROE 7.17%
Bulios Fair Price
$0.44
36.7% downside
Current Price
$0.7
Undervalued Fair Value Overvalued
According to Bulios Fair Price, SBMFF is currently overvalued relative to its market price. How does it work?
Bulios Fair Price is an estimate of a stock's fair value from the Bulios valuation model. It is an input for your own analysis, not investment advice. How does it work?
Piotroski F-Score Moderate
6/9Valuation
64 /100
Fair P/E 36.32x
P/B 2.70x
EV/EBITDA 11.76x
Growth
53 /100
Stable EPS growth 2.70%
Book val. growth 1.04%
Rev. growth 6.02%
Profitability
87 /100
Strong Gross margin 82.07%
FCF margin 24.47%
Net margin 7.36%
Quality
39 /100
Average ROIC 8.66%
Asset turnover 0.41x
ROE 7.17%
Debt
84 /100
Low Debt/Equity 0.52x
Net debt/EBITDA 1.12x
Current ratio 1.37x
Stability
75 /100
Stable Beta 0.61x
Profitable years 6
Rev. volatility 4.90%
Bulios Scoring describes a company's quality and track record, not its future return. A high score is not a buy signal. Learn more
Ask StockBot about SBMFF
Online
Sector
Healthcare
Industry
Medical - Pharmaceuticals
CEO
S. Y. Tse
Employees
21,435
Headquarters
Hong Kong
Upcoming events
01 APR
Earnings
Upcoming earnings report